Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Sanofi said on Tuesday it had stopped supplying Praluent, a popular cholesterol drug jointly developed by the French ...

Merck Unveils New Facility to Increase Vaccine Production CapacityDURHAM, N.C.-- (BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the ...

Can a drug that lowers “bad” cholesterol — and also raises the so-called “good cholesterol,” HDL — help to prevent ...

Therefore, cholesterol homeostasis is crucial for maintaining the basic biological functions of the lungs, and studying the regulatory mechanisms of cholesterol metabolism in the lungs is of great ...

New study shows eggs may decrease levels of 'bad' cholesterol Effect of eggs on health has long been disputed Eggs were added to the FDA's updated healthy claim food list in 2024 (NewsNation) — For ...

Merck said on Tuesday it was extending its pause on Gardasil shipments to China until at least the end of 2025 due to persistent weakness in demand for the blockbuster human papillomavirus vaccine ...

Merck on Tuesday said it will slash $3 billion in costs by the end of 2027 to be fully reinvested to support new product launches and its drug pipeline. The multiyear effort comes as Merck ...

Merck posted lower Q2 earnings as vaccine sales dropped, but oncology and animal health segments saw strong growth; 2025 guidance slightly raised.

Merck stock slid after the company’s earnings report failed to ease worries about the impending expiration of the patents protecting its megablockbuster cancer drug, Keytruda.

Along with its financial results for the second quarter of 2025, Merck revealed a restructuring plan to save $3 billion by the end of 2027.